Northern Trust Corp Ngm Biopharmaceuticals Inc Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 372,733 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
372,733
Previous 337,282 10.51%
Holding current value
$0
Previous $290,000 104.14%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.17 - $1.92 $41,477 - $68,065
35,451 Added 10.51%
372,733 $592,000
Q4 2023

Feb 13, 2024
SELL
$0.6 - $1.31 $4,073 - $8,893
-6,789 Reduced 1.97%
337,282 $290,000
Q3 2023

Nov 13, 2023
SELL
$1.05 - $3.37 $9,427 - $30,259
-8,979 Reduced 2.54%
344,071 $368,000
Q2 2023

Aug 11, 2023
SELL
$2.44 - $4.53 $2,371 - $4,403
-972 Reduced 0.27%
353,050 $914,000
Q1 2023

May 15, 2023
BUY
$3.72 - $5.4 $34,755 - $50,452
9,343 Added 2.71%
354,022 $1.44 Million
Q4 2022

Feb 13, 2023
BUY
$3.41 - $12.93 $19,123 - $72,511
5,608 Added 1.65%
344,679 $1.73 Million
Q3 2022

Nov 14, 2022
SELL
$12.59 - $17.67 $27,446 - $38,520
-2,180 Reduced 0.64%
339,071 $4.43 Million
Q2 2022

Aug 12, 2022
BUY
$10.58 - $17.5 $509,374 - $842,537
48,145 Added 16.43%
341,251 $4.38 Million
Q1 2022

May 13, 2022
SELL
$13.81 - $18.6 $157,544 - $212,188
-11,408 Reduced 3.75%
293,106 $4.47 Million
Q4 2021

Feb 08, 2022
BUY
$17.26 - $22.02 $87,232 - $111,289
5,054 Added 1.69%
304,514 $5.39 Million
Q3 2021

Nov 15, 2021
BUY
$20.15 - $26.19 $40,703 - $52,903
2,020 Added 0.68%
299,460 $6.3 Million
Q2 2021

Aug 13, 2021
BUY
$15.06 - $30.03 $355,416 - $708,708
23,600 Added 8.62%
297,440 $5.87 Million
Q1 2021

May 12, 2021
BUY
$24.99 - $31.93 $109,156 - $139,470
4,368 Added 1.62%
273,840 $7.96 Million
Q4 2020

Feb 11, 2021
SELL
$16.21 - $31.44 $100,891 - $195,682
-6,224 Reduced 2.26%
269,472 $8.16 Million
Q3 2020

Nov 16, 2020
BUY
$15.59 - $19.97 $219,148 - $280,718
14,057 Added 5.37%
275,696 $4.39 Million
Q2 2020

Aug 14, 2020
SELL
$11.97 - $23.47 $33,073 - $64,847
-2,763 Reduced 1.04%
261,639 $5.17 Million
Q1 2020

May 14, 2020
BUY
$10.0 - $19.51 $21,630 - $42,200
2,163 Added 0.82%
264,402 $3.26 Million
Q4 2019

Feb 14, 2020
BUY
$9.97 - $20.28 $1.61 Million - $3.27 Million
161,028 Added 159.1%
262,239 $4.85 Million
Q3 2019

Nov 13, 2019
BUY
$13.09 - $18.19 $721,848 - $1 Million
55,145 Added 119.71%
101,211 $1.4 Million
Q2 2019

Aug 13, 2019
BUY
$12.56 - $16.6 $578,588 - $764,695
46,066 New
46,066 $675,000

Others Institutions Holding NGM

# of Institutions
78
Shares Held
36.9M
Call Options Held
1.1K
Put Options Held
200
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email